Statistics

Total Visits

	Views
Safety of switching from intravenous to subcutaneous rituximab during first-line treatment of patients with non-Hodgkin lymphoma: the Spanish population of the MabRella study	92

File Visits

	Downloads
41131-1808.pdf	24

Select a period of time:

Number of views in the range

	Views
Safety of switching from intravenous to subcutaneous rituximab during first-line treatment of patients with non-Hodgkin lymphoma: the Spanish population of the MabRella study	34

Number of downloads in the range

	Downloads
41131-1808.pdf	12

Views

	Views
December 2025	2
January 2026	6
February 2026	1
March 2026	11
April 2026	6
May 2026	6
June 2026	2

untranslated

untranslated

Number of downloads in the period of time

Downloads
December 2025

3
January 2026

2
February 2026

1
March 2026

1
April 2026

0
May 2026

3
June 2026

2

untranslated

untranslated

Top country views

	Views
United States	19
Mexico	2
Turkey	2
China	2
Australia	1
Colombia	1
Ecuador	1
Egypt	1
United Kingdom	1
Honduras	1

Top countries by downloads

	Downloads
United States	8

Top cities views

	Views
San Jose	7
Ashburn	1
Azcapotzalco	1
Boca Raton	1
Cairo	1
Camillus	1
Cleveland	1
Coventry	1
Dolores Hidalgo	1
Kahramanmaraş	1

Top cities by downloads

	Downloads